Saudi Journal of Kidney Diseases and Transplantation (Jan 2010)

Late acute antibody mediated rejection after nine years of renal transplantation

  • Halim Medhat,
  • Al-Otaibi Torki,
  • Al-Waheeb Salah,
  • Tawab Khaled,
  • El Kholy Osama,
  • Nair Prasad,
  • Said Tarek,
  • Narayanan Nampoory M

Journal volume & issue
Vol. 21, no. 6
pp. 1111 – 1114

Abstract

Read online

Acute Antibody Mediated Rejection (AMR) is rarely reported as a long-term com-plication of renal transplantation, and it can present on top of another chronic pathology affecting the graft. A 45-year-old gentleman with chronic kidney disease due to unknown etiology received renal transplantation from his sister with 4 HLA mismatches. He received antithymocte globulin induction therapy and was maintained on steroids, azathioprine (AZA) and cyclosporine A (CsA). Up to eight years post-transplantation he was clinically and biochemically stable. He lost follow-up for about one year, and then presented with nephritic nephrotic syndrome and rise of serum creatinine (SCr.) to 210 μmol/L. Graft biopsy revealed picture suggestive of acute AMR on top of de novo membranoprolipherative glomerulonephritis (MPGN) with focal crescent formation, diffuse immune complex deposition and peri-tubular capillaries C4d positivity. Anti-HLA donor specific antibodies were highly positive for B and T cells class I and class II. The patient was treated with intravenous immunoglobulin, plasma exchange and anti-CD20 (rituximab). AZA was changed to mycophenolate mofetil and CsA to tacrolimus. He had partial response, but SCr. continued at 220 μmol/L.